GSK has offered to buy Tesaro for $75 per share in cash, a 110% premium on the company’s 30 day volume weighted average price of $35.67. The purchase price includes Tesaro’s debt.
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.